Wells Fargo Upgrades Ceradyne (CRDN) to Market Perform; XSAPI Thesis Confirmed
Tweet Send to a Friend
Wells Fargo upgrades Ceradyne, Inc. (Nasdaq: CRDN) from Underperform to Market Perform. Valuation range increased to $15-$17 from $14-$16.
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


